ARCHIVES

News Analysis: Generic Drug Industry’s Efforts to Eliminate Shortages Raises Antitrust Law Questions

This article is from The Cancer Letter archive.

Vol. 38 No. 17 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

Salmon Enthusiastic About Comprehensive Core Grant Plan

May 6, 1988

House Bill Gives NCI $135 Million Increase, NIH $846 Million for FY 1988 Over 1987 Budgets

August 7, 1987

Paraplatin Lengthened TTP In HER2+ Advanced Breast Ca

January 31, 2003

Monitoring of Clinical Trials Finds Two Major Problems; Investigators Are Suspended

August 19, 1983

Copeland Named Director, UF Cancer Center

February 10, 1995

Former NIH Director Varmus calls for more oversight of conflicts, expresses surprise at growth of Title 42 program.

May 21, 2004